Spirulina, a blue-green microorganism sold as a protein-rich supplement, has been tested for blood fats, blood pressure and allergies. Small trials show modest drops in blood pressure, blood fats and weight, mostly in people with raised values; one combined analysis found no clear blood-fat effect. With healthy starting numbers, expected gain is small. Main risks: contaminated products, rare allergic reactions and reported autoimmune flares. It supplies no usable vitamin B12. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | <100 mg/dL | Main lipid effect |
| Triglycerides | <150 mg/dL | Expected to change |
| Blood pressure | <120/80 mmHg | Expected to change |
| Fasting glucose | <100 mg/dL | Expected to change |
| ALT and AST | ALT 7–56 U/L; AST 10–40 U/L | Safety check: contamination-related liver injury |
| Vitamin B12 with MMA | B12 200–900 pg/mL; MMA <0.4 µmol/L | Safety check: inactive B12 analogs can mask deficiency |
| Hemoglobin | Men 13.5–17.5 g/dL; women 12.0–15.5 g/dL | Expected to change (rose in one trial) |
| Ferritin | Not specified in the ER | Paired with hemoglobin; plasma iron fell in one trial |
| Creatine kinase | 30–200 U/L | Safety check only with unexplained muscle pain |
Cadence: Baseline before starting; lipids, glucose markers, blood pressure and liver enzymes at 8–12 weeks, then lipids, glucose and blood pressure every 6–12 months; home blood pressure or glucose readings in the first 2–4 weeks alongside antihypertensive or glucose-lowering drugs; creatine kinase only with unexplained muscle pain.